載入...
An alternate conformation of HCV E2 neutralizing face as an additional vaccine target
To achieve global elimination of hepatitis C virus (HCV), an effective cross-genotype vaccine is needed. The HCV envelope glycoprotein E2 is the main target for neutralizing antibodies (nAbs), which aid in HCV clearance and protection. E2 is structurally flexible and functions in engaging host recep...
Na minha lista:
| 發表在: | Sci Adv |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Association for the Advancement of Science
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7380959/ https://ncbi.nlm.nih.gov/pubmed/32754640 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciadv.abb5642 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|